Ligand Announces Positive Preclinical Data on Small Molecule Erythropoietin Receptor Agonists December 4, 2010
Ligand Announces Presentation of Data from Multiple Studies of Dinaciclib by its Partner Merck at the ASH Annual Meeting December 3, 2010
Ligand Awarded $2 Million from U.S. Government Under the Patient Protection and Affordable Care Act November 2, 2010
Ligand to Present at the Oppenheimer 21st Annual Healthcare Conference on November 2 October 25, 2010
Ligand Announces Market Launch of Bazedoxifene in Japan and Spain for the Treatment of Postmenopausal Osteoporosis October 13, 2010
Ligand to Divest Combinatorial Compound Library and Screening Technology for $1.8 Million October 7, 2010